GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Osteopore Ltd (ASX:OSX) » Definitions » Debt-to-Asset

Osteopore (ASX:OSX) Debt-to-Asset : 0.43 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Osteopore Debt-to-Asset?

Osteopore's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$1.22 Mil. Osteopore's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$0.11 Mil. Osteopore's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was A$3.14 Mil. Osteopore's debt to asset for the quarter that ended in Dec. 2024 was 0.42.


Osteopore Debt-to-Asset Historical Data

The historical data trend for Osteopore's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osteopore Debt-to-Asset Chart

Osteopore Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial 0.04 0.02 0.02 0.26 0.43

Osteopore Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.26 0.24 0.43

Competitive Comparison of Osteopore's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, Osteopore's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Osteopore's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Osteopore's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Osteopore's Debt-to-Asset falls into.


;
;

Osteopore Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Osteopore's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Osteopore's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Osteopore  (ASX:OSX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Osteopore Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Osteopore's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Osteopore Business Description

Traded in Other Exchanges
N/A
Address
191 Street Georges Terrace, Level 5, Perth, WA, AUS, 6000
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.

Osteopore Headlines

No Headlines